Home >> Industry News >> FDA clears RapidPoint 500e Blood Gas Analyzer for critically ill

FDA clears RapidPoint 500e Blood Gas Analyzer for critically ill

image_pdfCreate PDF

April 2, 2020Siemens Healthineers announced that its RapidPoint 500e Blood Gas Analyzer has received clearance from the FDA. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room. The analyzer incorporates Integri-sense Technology, a comprehensive series of automated functional checks designed to deliver accurate test results at the point of care. Siemens’ Point of Care Ecosystem offers remote management for operators and devices located across multiple sites.

CAP TODAY
X